You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort
|
|---|---|
| Published in |
Breast Cancer Research, May 2013
|
| DOI | 10.1186/bcr3428 |
| Pubmed ID | |
| Authors |
Ashley C Godfrey, Zongli Xu, Clarice R Weinberg, Robert C Getts, Paul A Wade, Lisa A DeRoo, Dale P Sandler, Jack A Taylor |
| Abstract |
MicroRNAs (miRNAs) are small, non-coding, single-stranded RNAs between 18-22 nucleotides long that regulate gene expression. Expression of miRNAs is altered in tumor compared to normal tissue; there is some evidence that these changes may be reflected in the serum of cancer cases compared to healthy individuals. This has yet to be examined in a prospective study where samples are collected before diagnosis. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 50% |
| Scientists | 1 | 50% |
Mendeley readers
The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Denmark | 1 | <1% |
| Belgium | 1 | <1% |
| Egypt | 1 | <1% |
| Unknown | 103 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 26 | 24% |
| Student > Ph. D. Student | 22 | 21% |
| Student > Doctoral Student | 11 | 10% |
| Student > Master | 10 | 9% |
| Student > Bachelor | 5 | 5% |
| Other | 17 | 16% |
| Unknown | 16 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 28 | 26% |
| Medicine and Dentistry | 22 | 21% |
| Biochemistry, Genetics and Molecular Biology | 19 | 18% |
| Immunology and Microbiology | 4 | 4% |
| Engineering | 3 | 3% |
| Other | 12 | 11% |
| Unknown | 19 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#3,222,294
of 25,374,647 outputs
Outputs from Breast Cancer Research
#335
of 2,052 outputs
Outputs of similar age
#26,819
of 207,926 outputs
Outputs of similar age from Breast Cancer Research
#7
of 27 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,926 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.